Blink Device Company, a firm based in Seattle, Washington, won FDA clearance for and is releasing in the United States its TwitchView monitor. The device is used for monitoring the depth of neuromoscular blockade under anesthesia, and the company claims it is the first standalone electromyography (EMG) monitor available in the U.S. The company is working on obtaining clearance in Europe.
The system consists of a monitor, charging dock, and single use electrode arrays. The arrays can be placed on either hand in a matter of seconds and a press of a button begins “train-of-four” monitoring. The data collected and produced by the device can be dumped straight into the hospital’s electronic medical record.
“Monitors for neuromuscular blockade must be simple, reliable, and accurate,” in a statement said Elise Hyman, Blink’s VP of Marketing and Sales. “It is evident that these principles were top of mind when developing TwitchView, a device that streamlines clinical practice and remedies well-documented clinician concerns with currently available products. Having worked for an industry giant, I was privileged to meet innovators worldwide, but Blink stood out. I am truly excited to join this team and introduce this product to the healthcare community.”
Product page: TwitchView…